文献速递肝病消化道出血

肝硬化住院患者的 emerging 趋势——病因、并发症和结局与其他慢性健康状况的比较

Emerging Trends in Patients Hospitalised With Cirrhosis-Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions.
PubMed 文献 · Aliment Pharmacol Ther · 2025-07-28

该回顾性研究分析了德国柏林夏里特大学医院和莱比锡大学医院2011-2022年肝硬化住院患者,评估人口学、病因、并发症率和院内死亡率的变化趋势,并与主要慢性健康状况比较。结果显示肝硬化住院总数下降,但院内死亡率和并发症率上升;酒精性肝病持续为最常见病因(42%);静脉曲张出血和消化道出血的死亡率分别从2011年的15.53%和10.53%升至2022年的27.69%和31.25%;肝硬化住院患者院内死亡率达7.45%,尽管更年轻且合并症更少。

要点

  • 肝硬化住院总数下降,但院内死亡率和并发症率上升。
  • 酒精性肝病持续为最常见病因,占42%。
  • 静脉曲张出血死亡率从15.53%升至27.69%,消化道出血死亡率从10.53%升至31.25%。

核心结论

  • 肝硬化仍是重大临床和公共卫生挑战,在住院结局方面落后于其他主要合并症。
  • 需要关注改进资源分配和管理选择。

研究设计与样本

  • 回顾性研究,覆盖2011-2022年,在德国柏林夏里特大学医院和莱比锡大学医院(验证队列)进行。
  • 使用ICD-10编码识别肝硬化、其并发症和合并症患者,评估人口学、病因、并发症率和院内死亡率的变化。
  • 柏林队列纳入24,567例肝硬化住院患者,莱比锡验证队列纳入14,141例。

主要发现

  • 肝硬化住院总数下降,但院内死亡率和并发症率上升。
  • 酒精性肝病持续为最常见病因,占42%。
  • 静脉曲张出血住院死亡率从2011年的15.53%升至2022年的27.69%,消化道出血住院死亡率从2011年的10.53%升至2022年的31.25%。
  • 肝硬化住院患者院内死亡率为7.45%,尽管比其他慢性健康状况住院患者更年轻且合并症更少。
  • 其他慢性疾病住院患者的中位年龄增长幅度明显大于肝硬化住院患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aetiologies, complications and overall burden of cirrhosis have undergone changes in recent years. AIMS: This study aimed to assess the emerging trends in cirrhosis and its complications whilst also comparing them to other major chronic health conditions. METHODS: This retrospective study covering 2011-2022 was conducted at the Charité University Hospital Berlin and University Hospital Leipzig (validation cohort), Germany. ICD-10 codes were used to identify patients with cirrhosis, its complications and comorbidities. Changes in demographics, aetiologies, complication rates and inpatient mortality were assessed. Trends were compared against major chronic health conditions. RESULTS: 24,567 (Berlin) and 14,141 (Leipzig) inpatient admissions for cirrhosis were identified. Overall admission numbers have been decreasing; however, in-hospital mortality and complication rates have been increasing. Alcohol-related liver disease was persistently the most common cause of cirrhosis (42%). Mortality rates for admissions with variceal haemorrhage and gastrointestinal bleeding have increased from 15.53% and 10.53% in 2011 to 27.69% and 31.25% in 2022, respectively. Cirrhosis admissions had some of the highest rates of inpatient mortality (7.45%), despite being considerably younger and less comorbid than admissions with other chronic health conditions. Over time, the median age of admissions with other chronic diseases increased considerably more than admissions with cirrhosis. In the validation cohort, high inpatient mortality, increasing GI bleeding associated mortality, and complications rates were confirmed. CONCLUSION: Cirrhosis remains a significant clinical and public health challenge and is falling behind other major comorbidities with regard to inpatient outcomes. A focus on improved resource allocation and management options is warranted.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Pohl J, Walia N, Hofmann L, et al. Emerging Trends in Patients Hospitalised With Cirrhosis-Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions. Aliment Pharmacol Ther. 2025. PMID: 40720085. doi:10.1111/apt.70287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。